Background: Visit-to-visit office blood pressure variation (BPV) has prognostic implications independent from mean BP across several populations in the cardiovascular field. The association of BPV with outcomes in patients with myocardial infarction (MI) with systolic dysfunction and/or heart failure is yet to be determined.
INTRODUCTION
V isit-to-visit office blood pressure variability (BPV) has prognostic implications independent of mean blood pressure (BP) across several populations in the cardiovascular field [1] [2] [3] [4] [5] [6] . High BPV may be related to one or more of autonomic dysfunction, arteriosclerosis, increased sympathetic tone, arterial stiffness, some blood pressure-lowering agents and treatment nonadherence [1, [7] [8] [9] [10] [11] [12] .
Most studies have reported an association between high office SBPV and worse prognosis in the general population and in patients with hypertension [3] . However, in heart failure patients with reduced ejection fraction (HF-REF) the results have been inconsistent [1, 4] . For example, in subanalysis derived from the effects of high-dose versus lowdose losartan on clinical outcomes in patients with heart failure trial (HEAAL), a high BPV was found to be associated with poorer cardiovascular outcomes [1] . On the other hand, in the Ivabradine and outcomes in chronic heart failure trial (SHIFT) was the low BPV that was associated with worse outcomes [4] .
To the best of our knowledge, the association between office BPV and outcomes in patients with myocardial 
METHODS

Study population
The derivation cohort was patients enrolled in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) [13, 14] . The Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) was used for validation [15, 16] . Full details of the design and results of each trial are published [13, 16] . In short, both trials enrolled patients with left ventricular systolic dysfunction, heart failure or both between 12 h and 14 days after acute MI.
The studies were all conducted in accordance with the Declaration of Helsinki and approved by site ethics committees. All participants gave written informed consent to participate in the trials.
Outcomes
The primary outcome in both trials was all-cause death (with a coprimary endpoint of cardiovascular death or cardiovascular hospitalization in EPHESUS). We analyzed the association between BPV and the primary outcome of death in both EPHESUS and OPTIMAAL, exploring the association of BPV with cardiovascular death and cardiovascular hospitalization in the EPHESUS trial.
Visit-to-visit blood pressure variation
Blood pressure was measured in each trial at each visit after 5 min of rest in the seated position by a trained observer using an automated oscillometric monitor. Three measures were performed systematically and the mean of the three measures was calculated and inserted in the dataset. BPV was previously shown to be reproducible and applicable in clinical practice [17] . The average of several measurements over time has been shown to provide more precise information on the risk for cardiovascular events in a population of patients with stable chronic cardiovascular disease [18] . Mean BP was calculated using measurements at each follow-up visit. BPV was calculated as a coefficient of variation, that is, the ratio of the SD to the mean (CV ¼ SD/meanÃ100%). Measurements from all follow-up visits were included. Altogether, a mean AE SD of 7.7 AE 2.7 visits (range 2-14) were available in EPHESUS and 8.8 AE 3.0 (range 2-12) in OPTIMAAL.
Statistical methods
Continuous variables were expressed as mean AE SD and categorical variables as frequencies and proportions. For comparison of means and proportions, one-way ANOVA test and chi-square test were used, respectively.
Factors associated with BPV (tertiles) were first identified using univariate followed by multivariable stepwise backward conditional multinomial logistic regression using the intermediate BPV category as reference. The covariates inserted in the models were identified among patient characteristics listed in Table 1 with a P value less than 0.1.
Linearity was assessed by plotting the b estimates vs. mean by quintiles of the studied independent variable. Variables were then categorized in order to obtain log-linearity. Multinomial logistic regression data are presented as odds ratios (OR) and respective 95% confidence intervals (95% CI).
Cox proportional hazard regression models were used to model long-term survival as a function of the formulas both in univariable and multivariable analysis. Proportional hazards assumptions for dependent variables were visually assessed by plotting the log[Àlog(S(t))] function as a function of survival time (t), where S(t) represents the survival function. In the multivariable models, the adjustment covariates were chosen from demographic (age and sex), clinical/pharmacological (mean SBP, heart rate, history of diabetes mellitus, hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, left ventricular ejection fraction (LVEF), diuretics, angiotensin converting enzyme inhibitors/angiotensin receptor blockers (ACEi/ARB), and beta-blockers use, and also eplerenone allocation), and laboratory variables [hemoglobin, sodium, and estimated glomerular filtration rate calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation [19] ] that were previously found to be clinically relevant [20] . Additional adjustment in smoking status, alcohol consumption, mean heart rate, and heart rate variability was also performed. These variables had a small proportion of missing values (<10%) and no multiple imputation was performed. We assessed interactions with the Log of time, age, sex, mean SBP, heart rate, pulse pressure, and eplerenone allocation, and none were significant (all P > 0.10). The correlation between BPV, BP SD, mean BP and pulse pressure are presented in the 'Results' section. Whenever the correlation between two variables was greater than 0.5, only one of them was inserted in the multivariable models because of colinearity issues.
The linearity assumption of the relationship between BPV and the log-hazard of outcome was assessed using restricted cubic splines with three knots equally spaced at the 10th, 50th, and 90th percentiles according to the Harrell's rule [21] . The Wald test associated with the nonlinear component was statistically significant, and a nonlinear relationship was assumed regarding all the studied outcomes (P value for linearity <0.001). Supplemental Figure 1 and 2, http://links.lww.com/HJH/A928.
A P value less than 0.05 was considered as statistically significant.
All analysis was performed with the R software, R Core Team (2013). [R: a language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria, URL: http://www.R-project.org/)].
RESULTS
Baseline characteristics
The BPV tertiles were 7.7% or less (n ¼ 2180), 7.8-10.9% (n ¼ 2163), and greater than 10.9% (n ¼ 2164). The absolute number of BP evaluations was similar across each tertile (n % 8). The mean SBP at baseline in each tertile was 119.8 AE 14. Compared with those in the middle and lower BPV tertiles, patients in the upper BPV tertile in EPHESUS were older and more often women, but less often Caucasian. They more commonly had hypertension, diabetes, peripheral artery disease, and chronic obstructive pulmonary disease; they were more often treated with loop diuretics and ACEi/ ARBs. Patients in the upper BPV tertile also had a lower mean left ventricular ejection fraction, hemoglobin, and estimated glomerular filtration rate (all P < 0.001). Similar results were observed in the OPTIMAAL trial (Table 1 and  Supplemental Table 1 , http://links.lww.com/HJH/A928).
The integer (%) of BPV tertiles was also similar between the EPHESUS and OPTIMAAL trials (low 8% in EPHESUS vs. 9% in OPTIMAAL and high !11% for both; Table 1 and  Supplemental Table 1 , http://links.lww.com/HJH/A928).
Logistic regression analysis to determine the factors associated with blood pressure variability
In the EPHESUS multivariable logistic regression analysis, lower BPV was independently and positively associated with Caucasian race [odds ratio (OR), 95% CI 1.37, 1.10-1.69) and pulse pressure less than 40 mmHg (OR, 95% CI (Table 2 ). In the OPTIMAAL trial, data hypertension and estimated glomerular filtration rate less than 60 ml/min per 1.73 m 2 were also associated with high BPV (Supplemental Table 2 , http:// links.lww.com/HJH/A928).
Prognostic associations
BPV was independently associated with worse prognosis in a U-shaped manner. In EPHESUS, both low and high BPV were associated with higher event rates of death, Cardiovascular death and the composite of cardiovascular death Figure 1 , and Supplemental Table 3 , http://links.lww.com/HJH/A928). A sensitivity analysis including patients with a minimum of three visits and further adjustment on smoking status and alcohol consumption was also performed, providing overlapping results to those above described (Supplemental Table 4 , http://links.lww.com/HJH/A928). Additional adjustment on the mean heart rate and its variability did not change the associations and no statistical interaction was present (Supplemental Table 5 , http://links.lww.com/HJH/A928).
Data consistency
For simplification of the manuscript, the data shown herein refer to SBPV, referred to as BPV throughout the text. The results for DBPV were similar to those of SBPV. Supplemental Figure 3 , http://links.lww.com/HJH/A928. SBPV and DBPV were moderately correlated (Pearson correlation ¼ 0.51, P < 0.0001).
The correlation between the SD and the coefficient of variation of both SBPV and DBPV was strong (Pearson correlation ¼ 0.97 for both) and provided overlapping results.
SBPV was weakly correlated with mean SBP and mean pulse pressure (Pearson correlation <0.20). The prognostic associations of BPV were independent from the mean BP and pulse pressure.
DISCUSSION
Among MI patients with systolic dysfunction and/or heart failure, those with low BPV differed substantially from those with high BPV with respect to their baseline characteristics. Despite these baseline differences, BPV was independently associated with worse prognosis in a U-shaped manner, that is, both low and high BPV were independently associated with higher event rates compared with the rates observed in patients with intermediate BPV. These findings were replicated in two independent MI cohorts and provide novel information about BPV in this population.
The mean BPV (%9%) observed in these MI patients with systolic dysfunction and/or heart failure was similar to that described for other high cardiovascular-risk populations such as heart failure with REF, hypertension, stroke, Visit-to-visit blood pressure variation coronary artery disease, and receiving hemodialysis [1, 5, 22, 23] . However, in these other populations, a high BPV was consistently associated with worse prognosis. The only exception was in SHIFT, where in patients with HF-REF, a low BPV was associated with higher event rates (compared with patients with intermediate and high BPV tertiles) with a significant statistical interaction between BPV and mean SBP whereby those at the highest risk were in the subgroup with the lowest third of mean SBP and lowest third of BPV [4] . However, the mechanisms underpinning this association of low BPV with adverse outcomes in SHIFT are unknown [4] . One potential explanation might relate to the association between low BPV and low pulse pressure in EPHESUS (although not in OPTIMAAL). In patients with acute MI and/or HF-REF, low pulse pressure may reflect low stroke volume, and in these populations a lower pulse pressure is associated with worse outcomes [24] [25] [26] . Consequently, in EPHESUS, low BPV, might also reflect a lower stroke volume. However, this remains uncertain as the U-shaped association of V BPV was independent of the pulse pressure and no statistical interaction was observed. The association of high BPV with higher morbidity and mortality reported in several patient populations has been attributed to modifications on the factors influencing regional circulation and blood pressure [1, [10] [11] [12] . In EPHE-SUS, high BPV was positively associated with older age, renal dysfunction, low SBP, and higher use of ACEi/ARBs. In hypertensive populations, the use of ACEi/ARBs (and beta-blockers) was also found to be associated with increased BPV compared with calcium-channel blockers and nonloop diuretics [9] . Nonetheless, the clinical relevance of these findings is yet to be determined and warrants prospective assessment [9] .
To the best of our knowledge, this is the first report of a U-shaped BPV association with outcomes in MI populations with systolic dysfunction and/or heart failure. The similar number of measures across the BPV spectrum and the independence and replication of these results in two independent cohorts make these findings robust [23] .
Currently, there are multiple evidence-based life-saving therapies for patients with the characteristics of those described herein [27, 28] . Specifically targeting BPV in this population seems unlikely because one would have to avoid both low and high BPV simultaneously. However, further studies are warranted to understand the underlying mechanisms that link low BPV to increased morbidity and mortality rates.
Limitations
Several limitations in our study should be noticed. First, this is a posthoc analysis of two randomized controlled trials, therefore, the limitations inherent to observational studies are present in our report and no causality can be established. Second, the differences reported between BPV groups are likely because of between-group differences in patients' characteristics, rather than to on-treatment differences. Third, adherence to treatment along the trial is not reported in the dataset, however, in randomized trials patients' high motivation and close follow-up make overall adherence uncharacteristically high as compared with population-based studies. Fourth, these trials did not target hypertension, hence there was no predefined BP intervention at baseline, which may have influenced BPV. Moreover, we also did not observe a treatment allocation interaction. Fifth, the EPHESUS and OPTIMAAL trials had different inclusion criteria. Although EPHESUS required a LVEF 40% or less, OPTIMAAL included patients with a LVEF 35% or less or a left-ventricular end-diastolic dimension at least 65 mm and/or a new Q-wave anterior-wall acute myocardial infarction, or any reinfarction with previous pathological Q-waves in the anterior wall. These differences between the studies may account for the observed discrepancies in the factors associated with BPV. However, they reinforce the external validity of our results in complicated MI populations. Lastly, the mechanisms underlying BPV are not completely understood (especially for the association of low BPV with worse prognosis) and further studies are required. Specifically, high sympathetic activity could be associated with low BPV and portend adverse prognosis. However, we do not have sympathetic activity indexes available in the datasets.
In conclusion, in MI patients with systolic dysfunction and/or heart failure, BPV is associated with worse prognosis in a U-shaped fashion independently of the mean BP. Further studies are warranted to understand the underlying mechanisms related to BPV.
